Skip to main content
. Author manuscript; available in PMC: 2024 Mar 22.
Published in final edited form as: J Nucl Cardiol. 2018 Feb 7;25(3):742–753. doi: 10.1007/s12350-018-1200-4

Table 1.

MI patient characteristics

Variable Value

Age (years) 62.9 ± 8.6
Males, n 76 (82.6%)
BMI (kg/m2) 24.58 ± 3.02
Hypertension, n 68 (73.9%)
Diabetes, n 31 (33.7%)
Hyperlipidemia, n 11 (12.0%)
COPD, n 2 (2.2%)
History of angina pectoris, n 74 (80.4%)
Stenosis vessel number, n 2.51 ± 0.70
CCS class 1.53 ± 1.04
NYHA class 1.85 ± 1.13
LVEDVi (ml/m2) 72.83 ± 35.94
LVESVi (ml/m2) 42.68 ± 35.13
LVEF (%) 47.91 ± 15.88
STS 8.5 (1.3–18.8)
TPD (%) 16.41 ± 14.20
Viable myocardium (%) 6 (2–11.8)
Scar (%) 5 (2–9.8)
Reduced thickening segments/normal perfusion segments (%) 9.55 (0.00–36.46)
Reduced thickening segments/decreased perfusion segments (%) 66.67 (20.00–100.00)

MI, Myocardial infarction; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CCS, Canadian class classification of angina pectoris; NYHA, New York Heart Association classification of heart failure; LVEDVi, left ventricular end-diastolic volume index; LVESVi, left ventricular end-systolic volume index; LVEF, left ventricular ejection fraction; STS, summed thickening score; TPD, total perfusion deficit